114 related articles for article (PubMed ID: 7332542)
21. Influence of enzymatic phospholipid cleavage on the permeability of the erythrocyte membrane: III. Discrimination between the causal role of split products and of lecithin removal.
Deuticke B; Grunze M; Forst B; Luetkemeier P
J Membr Biol; 1981 Mar; 59(1):45-55. PubMed ID: 7241575
[TBL] [Abstract][Full Text] [Related]
22. [Destabilization of erythrocyte lipid structures in blood coagulation].
Rubin VI; Bezrukova GA
Vopr Med Khim; 1990; 36(3):32-4. PubMed ID: 2382423
[TBL] [Abstract][Full Text] [Related]
23. Properties of rabbit erythrocytes treated with phospholipase A2 from bee venom.
Vaysse J; Pilardeau P; Garnier M
Comp Biochem Physiol A Comp Physiol; 1986; 83(4):715-9. PubMed ID: 2870863
[TBL] [Abstract][Full Text] [Related]
24. Selective removal of lipids from the outer membrane layer of human erythrocytes without hemolysis. Consequences for bilayer stability and cell shape.
Haest CW; Plasa G; Deuticke B
Biochim Biophys Acta; 1981 Dec; 649(3):701-8. PubMed ID: 7317423
[No Abstract] [Full Text] [Related]
25. Stimulation of fatty acid methylation in human red cell membranes by phospholipase A2 activation.
Engelsen SJ; Zatz M
Biochim Biophys Acta; 1982 Jun; 711(3):515-20. PubMed ID: 7104380
[TBL] [Abstract][Full Text] [Related]
26. Effect of liver plasma membrane fluidity on endogenous phospholipase A2 activity.
Petkova DH; Momchilova-Pankova AB; Koumanov KS
Biochimie; 1987; 69(11-12):1251-5. PubMed ID: 3129030
[TBL] [Abstract][Full Text] [Related]
27. Glucose transport into human erythrocytes treated with phospholipase A2 or C.
Fujii H; Miwa I; Okuda J; Tamura A; Fujii T
Biochim Biophys Acta; 1986 Aug; 883(1):77-82. PubMed ID: 3730428
[TBL] [Abstract][Full Text] [Related]
28. Asymmetric manipulation of the membrane lipid bilayer of intact human erythrocytes with phospholipase A, C, or D induces a change in cell shape.
Fujii T; Tamura A
J Biochem; 1979 Nov; 86(5):1345-52. PubMed ID: 521437
[TBL] [Abstract][Full Text] [Related]
29. [Changes in the physico-chemical properties of synaptosomal membranes induced by phospholipase A2].
Erin AN; Tiurin VA; Brusovanik VI; Gorbunov NV; Selishcheva AA
Biokhimiia; 1985 Mar; 50(3):507-13. PubMed ID: 2986735
[TBL] [Abstract][Full Text] [Related]
30. Phospholipid asymmetry in the membranes of intact human erythrocytes and in spectrin-free microvesicles derived from them.
Raval PJ; Allan D
Biochim Biophys Acta; 1984 May; 772(2):192-6. PubMed ID: 6722143
[TBL] [Abstract][Full Text] [Related]
31. Involvement of spectrin in the maintenance of phase-state asymmetry in the erythrocyte membrane.
Williamson P; Bateman J; Kozarsky K; Mattocks K; Hermanowicz N; Choe HR; Schlegel RA
Cell; 1982 Oct; 30(3):725-33. PubMed ID: 7139713
[TBL] [Abstract][Full Text] [Related]
32. Differential inhibitory effects by phospholipase A2 on guanylate and adenylate cyclases of Tetrahymena plasma membranes.
Kameyama Y; Kudo S; Ohki K; Nozawa Y
Jpn J Exp Med; 1982 Aug; 52(4):183-92. PubMed ID: 6129336
[TBL] [Abstract][Full Text] [Related]
33. Different susceptibilities of platelet phospholipids to various phospholipases and modifications induced by thrombin. Possible evidence of rearrangement of lipid domains.
Wang CT; Tsai WJ; Chang SM; Shiao YJ; Yang CC
Biochim Biophys Acta; 1987 May; 899(2):205-12. PubMed ID: 3580366
[TBL] [Abstract][Full Text] [Related]
34. [Turnover of the fatty acid moiety of complex lipids in blood cell membrane and its physiological significance--activation mechanism of platelet phospholipase A2].
Kannagi R
Seikagaku; 1987 Dec; 59(12):1291-307. PubMed ID: 3329667
[No Abstract] [Full Text] [Related]
35. Effects of phospholipase A2 treatment of human erythrocyte membranes on the rates of spectrin-actin dissociation.
Gottlieb MH
Biochim Biophys Acta; 1982 Mar; 686(1):133-6. PubMed ID: 7066319
[TBL] [Abstract][Full Text] [Related]
36. Comparison of a relatively toxic phospholipase A2 from Naja nigricollis snake venom with that of a relatively non-toxic phospholipase A2 from Hemachatus haemachatus snake venom--I. Enzymatic activity on free and membrane bound substrates.
Condrea E; Yang CC; Rosenberg P
Biochem Pharmacol; 1980 Jun; 29(11):1555-63. PubMed ID: 7396986
[No Abstract] [Full Text] [Related]
37. [Phospholipase A2 and reacylation of phospholipids].
Muratova UZ; Bornikov VT; Saatov TS
Biokhimiia; 1987 Jul; 52(7):1068-71. PubMed ID: 3663745
[TBL] [Abstract][Full Text] [Related]
38. Erythrocyte membrane glycerophospholipid organization is normal in multiple sclerosis.
Hunter MI; Lao MS; Davidson DL
Neurochem Res; 1984 Jan; 9(1):103-8. PubMed ID: 6717729
[TBL] [Abstract][Full Text] [Related]
39. Exploring the action and specificity of cobra venom phospholipase A2 toward human erythrocytes, ghost membranes, and lipid mixtures.
Adamich M; Dennis EA
J Biol Chem; 1978 Jul; 253(14):5121-5. PubMed ID: 670181
[TBL] [Abstract][Full Text] [Related]
40. The lipid requirement of the (Ca2+ + Mg2+)-ATPase in the human erythrocyte membrane, as studied by various highly purified phospholipases.
Roelofsen B; Schatzmann HJ
Biochim Biophys Acta; 1977 Jan; 464(1):17-36. PubMed ID: 137746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
